Brief: SK Holdings Says Sold Shares In SK Biopharmaceuticals In Block Deal Worth $991 Mln
Feb 24 (Reuters) -
* SK HOLDINGS SAYS SOLD SHARES IN SK BIOPHARMACEUTICALS IN
BLOCK
DEAL WORTH 1.1 TRILLION WON ($991.43 million)
Source text for Eikon: https://bit.ly/3dFwJYN
Further company coverage: 034730.KS
($1 = 1,109.5100 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract